
New Weight Loss Drug Preserves Muscle Mass in Trials
A promising triple-action medication could help people lose weight without sacrificing muscle. Retatrutide shows potential for safer weight loss with fewer side effects than earlier medications.
Find uplifting stories about heroes, innovations, and solutions
12708 results for "weight loss medication"

A promising triple-action medication could help people lose weight without sacrificing muscle. Retatrutide shows potential for safer weight loss with fewer side effects than earlier medications.

People using GLP-1 weight loss medications may not need weekly injections forever. A new study shows many patients maintain their weight loss while spacing out doses to every two or even six weeks.

A new weight-loss pill from AstraZeneca helped trial participants lose nearly 12% of their body weight in just nine months, offering fresh hope in the race to make weight management easier. The tablet could soon give doctors and patients another powerful tool in fighting obesity.

A groundbreaking UCLA study of nearly 94,000 diverse patients discovered how genetics predict who responds best to popular weight loss medications like Ozempic. This breakthrough could transform how doctors prescribe treatments, ensuring medications work better for everyone.

A daily pill helped patients lose 16% of their body weight in 44 weeks, outperforming other oral medications in development. The breakthrough could make obesity treatment more accessible to millions who avoid injections.

A breakthrough study shows the diabetes drug semaglutide helps older adults lose significant weight safely while improving heart health. Nearly half of participants over 65 achieved at least 15% weight loss in just over a year.

Postmenopausal women combining hormone therapy with a popular weight loss drug lost 35% more weight than those taking the medication alone. The finding could transform how millions of women manage weight gain after menopause.

Breakthrough weight loss medications like Ozempic could help address rising obesity rates among people living with HIV in South Africa. Early research suggests these drugs work just as well for HIV patients as everyone else.

New research challenges concerns that popular GLP-1 medications like Wegovy and Zepbound cause excessive muscle loss. The findings offer reassurance to millions considering or using these breakthrough weight-loss treatments.

Scientists are testing a breakthrough obesity treatment that helps people lose up to a third of their body weight without sacrificing muscle mass. The triple-action drug retatrutide could solve one of the biggest problems with current weight-loss medications.

Amazon's One Medical is bringing weight-loss drug treatment into primary care offices nationwide, offering patients a safer alternative as demand for medications like Ozempic surges. The move addresses growing concerns about patients receiving improper care from standalone telehealth providers.

Popular weight loss medications are showing an unexpected benefit for people with chronic sinus problems and obesity. A five-year study found patients taking these drugs needed 40% fewer repeat surgeries after sinus operations.

A new obesity treatment from pharmaceutical company Boehringer has shown promising results, helping patients lose an average of 16.6% of their body weight in clinical trials. The breakthrough adds another tool to the growing arsenal of effective weight loss medications changing lives worldwide.

Popular weight-loss medications like Ozempic may dramatically slow the spread of certain cancers, according to groundbreaking research from Cleveland Clinic. The study found up to 50% lower progression rates for four major cancer types among patients taking these drugs.

Two pharmaceutical giants just released the first truly effective weight loss pills after years of failed attempts. The new medications could make obesity treatment as easy as taking a daily tablet.

German researchers have developed a breakthrough drug that outperformed popular weight-loss medications in early tests, targeting five body systems at once. The "quintuple agonist" could mean better results with fewer side effects, though human trials are still needed.

NIH researchers discovered why popular GLP-1 medications like Ozempic eventually stop working as well, and they found a possible solution. The breakthrough could help millions push past frustrating weight loss plateaus.

Scientists discovered that popular diabetes and weight-loss medications might fight depression by feeding helpful gut bacteria, not by acting on the brain directly. This breakthrough could lead to probiotic treatments for people battling both obesity and depression.

Danish researchers found that popular GLP-1 drugs like semaglutide reduced asthma flare-ups by a quarter and cut inhaler dependence by 14%. The breakthrough suggests these medications do more than just help with weight loss.

Millions of patients will regain access to Zepbound after CVS Caremark reversed its decision to drop the popular weight loss medication. Patient voices made the difference in bringing the drug back to insurance coverage.
Showing 20 of 12708